(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COCHLEAR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

COCHLEAR

ST13

US500000079308437

Class

5

Filing

79308437

Registration

6709015

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

05/08/2026

Trademark type

Word

Nice classes

5

Filing date

02/17/2021

Registration date

04/26/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/26/2022

Last transaction

05/08/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

AU

Examiner

FRENCH, CURTIS W

Law office

M60

Current location

TMO LAW OFFICE 115

Holders and representatives

Holders

Cochlear Limited

Representatives

Jason Vogel KILPATRICK TOWNSEND & STOCKTON LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of inflammation or fibrosisthe preservation or improvement of neural structures or functionsthe inhibition of osteoneogenesis; medical preparations for the treatment of inflammation or fibrosisthe preservation or improvement of neural structures or functionsthe inhibition of osteoneogenesis; pharmaceutical drugs for the treatment of inflammation or fibrosisthe preservation or improvement of neural structures or functionsthe inhibition of osteoneogenesis; corticosteroids; dexamethasone; anti-inflammatoryanti-fibroticanti-apoptoticanti-oxidantimmunosuppressingneuroprotectiveneurotrophic and neuroregenerative drugs; pharmaceutical sprays for the body for the treatment of inflammation or fibrosisthe preservation or improvement of neural structures or functionsthe inhibition of osteoneogenesis; medical disinfectants; antiseptics; disinfectant medicated cleaning preparations for instruments; chemical reagents for medical purposes; chemical preparations for medical purposesfor the treatment of inflammation or fibrosisthe preservation or improvement of neural structures or functionsthe inhibition of osteoneogenesis * ; all of the aforesaid excluding medical disinfectants *

Publications

History of USPTO decisions and trademark events.

33 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/07/2026

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

08/29/2025

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

08/12/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

08/05/2024

NURC

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

01/09/2024

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

12/04/2023

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

12/04/2023

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

11/05/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/26/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/05/2022

FIMP

FINAL DISPOSITION PROCESSED

09/05/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

08/14/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/26/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/26/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/08/2022

PUBO

PUBLISHED FOR OPPOSITION

02/08/2022

GPNX

NOTIFICATION PROCESSED BY IB

02/06/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/19/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/19/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/19/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/04/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/14/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/13/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/13/2021

RFNT

REFUSAL PROCESSED BY IB

07/05/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/11/2021

RFRR

REFUSAL PROCESSED BY MPU

06/11/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/08/2021

CNRT

NON-FINAL ACTION WRITTEN

06/07/2021

DOCK

ASSIGNED TO EXAMINER

06/03/2021

MAFR

APPLICATION FILING RECEIPT MAILED

04/13/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/09/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/08/2021

Continuous trademark protection

Get notified about every new filing that threatens COCHLEAR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.